Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro can affect your menstrual cycle. Some women on tirzepatide report changes to their period — including timing, flow and cramping — particularly in the early weeks of treatment. These shifts are likely connected to rapid weight loss and its effect on hormone levels, not a direct action of the medicine on the reproductive system. Mounjaro is a prescription-only medicine; a qualified prescriber assesses your full health picture before it is prescribed. If you notice significant or persistent menstrual changes on Mounjaro, that's worth raising with your prescribing team.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide doesn't act directly on the ovaries or uterus. Its effect on menstruation runs through a more indirect route: body fat is metabolically active tissue that produces oestrogen. When you lose weight relatively quickly (which many people do in the first few months of Mounjaro) oestrogen production can drop or fluctuate. The hypothalamic–pituitary–ovarian axis, which coordinates the menstrual cycle, is sensitive to these hormonal shifts. The result is that cycle length, flow or both can change, sometimes noticeably.
The same mechanism explains why significant weight loss from any cause (surgery, illness, intense dieting) can disrupt periods. Mounjaro is simply a particularly effective way of achieving that weight loss, so the effect can emerge faster than it might with lifestyle change alone. More about how tirzepatide works as a medicine is covered in our full clinical overview.
There is no published trial data specifically measuring menstrual outcomes as a primary endpoint in the SURMOUNT programme. What we know comes from self-reported patterns and the established science of weight-loss-related hormonal change. Anecdotal reports are common enough that it is a question our prescribers hear regularly, and the NHS tirzepatide medicines page advises speaking to your doctor if you experience unexpected menstrual changes on treatment.
The range is wide. Some women find their periods arrive earlier or later than usual, a day or two of variation is common during active weight loss, and for some the shift is more pronounced. Others notice lighter flow than usual, or, less often, temporarily heavier bleeding. Period pain can also feel different; if that's something you're tracking, the detail on Mounjaro and period pain goes into that specifically.
A smaller number of women report a missed period altogether, especially in the first one to three months. This is typically tied to the pace of early weight loss rather than to a dose level. If your period is late rather than absent, what a late period on Mounjaro actually means is worth reading before drawing conclusions. And if periods have stopped entirely, the guidance on missing periods on Mounjaro covers when to seek advice and what's likely going on.
Most women find the pattern settles once weight loss slows and body composition stabilises. That doesn't mean ignoring it in the meantime, any menstrual change that is severe, prolonged, or accompanied by pain or other symptoms should be checked by a clinician. A home pregnancy test is always a sensible first step if a period is genuinely absent and pregnancy is possible.
Yes, and this is the most clinically important menstrual-adjacent point. Because Mounjaro slows gastric emptying, the absorption of oral contraceptive pills can be reduced, particularly in the first weeks of treatment and after each dose step up. NHS England's guidance on weight-management injections is explicit: women taking the oral contraceptive pill should use an additional non-oral method of contraception, such as condoms, for the first four weeks of Mounjaro treatment and for four weeks after every dose increase.
Transdermal contraception (patches, implants, IUDs) is not affected by gastric emptying and carries no equivalent concern. If your current contraception is an oral pill and you're starting or escalating Mounjaro, discuss this with your prescriber before your next dose. This interaction is one reason the NHS England wraparound care guidance treats contraception as a routine topic at the prescribing consultation, not an afterthought.
The broader question of fertility is worth a brief note too. Weight loss can restore ovulation in women with conditions like PCOS where cycle irregularity was already present. That's generally positive, but it means effective contraception matters even more during active treatment, particularly given that Mounjaro is not recommended during pregnancy or for those trying to conceive.
Probably not your injection schedule. Mounjaro is taken once a week on whatever day suits you, many people keep their pen in the fridge door and set a phone reminder to the same day and time each week. Period timing doesn't change that. What might be worth tracking is whether GI side effects feel more pronounced at certain points in your cycle; some women notice that nausea is easier to manage in the days just before or after their period, though this isn't universal and there's no clinical guidance recommending cycle-timed dosing.
If your periods have become notably irregular since starting Mounjaro, let your prescriber know at your next review. Regular clinical check-ins are part of how responsible prescribing works, every repeat with nume includes a clinical re-review, not just a rubber stamp. You can find an overview of how Mounjaro and periods interact more broadly if you want the fuller picture, or read the detail on tirzepatide and the menstrual cycle for more on the hormonal mechanism. For context on the treatment itself (including what private prescribing costs) the Mounjaro cost overview is a practical starting point.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.